Header Logo

Connection

Donald Jensen to Quinoxalines

Back to Details
This is a "connection" page, showing publications Donald Jensen has written about Quinoxalines.
Donald Jensen
Connection Strength
0.675
Quinoxalines
  1. Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Des Devel Ther. 2019; 13:2565-2577.
    View in: PubMed
    Score: 0.675
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.